PULM CIRC 润色咨询

Pulmonary Circulation

出版年份:暂无数据 年文章数:1046 投稿命中率: 开通期刊会员,数据随心看

出版周期:Quarterly 自引率:10.5% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2174024, encodeId=de9a21e40243c, content=审稿速度:12.0 | 投稿命中率:75.0<br>偏重的研究方向:PE<br>经验分享:5月份投稿,今天接收的,两次大修直接accept,编辑很好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ca58126637, createdName=ms7000000341210053, createdTime=Sun Dec 10 13:19:19 CST 2023, time=2023-12-10, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2164658, encodeId=97ff21646585b, content=Awaiting Reviewer Selection需要多久?已投稿2周还是这个状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/4UjrU2XV6eQeXoLxSau95Fn1q1qGfJSw9gYZsHKr3lVESVxDfUMiahTuIQfzSe87XNvZfuI7GJqFENbgqYIHKmA/132, createdBy=16c22203057, createdName=乐观的526, createdTime=Tue Oct 24 17:39:19 CST 2023, time=2023-10-24, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=1106972, encodeId=34b411069e2d0, content=IF是什么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Wed Dec 29 14:52:53 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1106971, encodeId=35c011069e127, content=长篇幅讨论是否展示作者对课题的思考?审稿人对MS印象好?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Wed Dec 29 14:52:53 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1081300, encodeId=168010813007f, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:肺动脉高压<br>经验分享:2020年成功发表了一篇,近期有一篇收到收录通知,但是通知出版商更改了,请知情的亲们告知是否这样, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=182, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d5662461428, createdName=1241ab49m01(暂无昵称), createdTime=Fri Dec 17 21:33:20 CST 2021, time=2021-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562464, encodeId=38e6562464e1, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:个人感觉很好的一个杂志,投的肺血管病相关的meta,大修一次小修一次然后接收,要收OA费用, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=355, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200616/8841a9ca101a4fd9bdba0dd8498a9e0d/3f033a568887417cba0f0a9a4d0ac943.jpg, createdBy=d4671707910, createdName=ms5000001929854262, createdTime=Sun Oct 28 00:00:00 CST 2018, time=2018-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=846521, encodeId=dadf84652152, content=心血管的好期刊还是挺多,这个只能算是很普通的期刊。想投高分的就考虑换一个 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=300, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7a645414058, createdName=ms2534931155419844, createdTime=Wed Aug 22 16:39:27 CST 2018, time=2018-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544670, encodeId=94d75446e092, content=我只是想添加一个IF..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=419, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=04d11730917, createdName=jdsf1291, createdTime=Fri Jul 21 11:04:00 CST 2017, time=2017-07-21, status=1, ipAttribution=)]
    2023-12-10 ms7000000341210053 来自江苏省

    审稿速度:12.0 | 投稿命中率:75.0
    偏重的研究方向:PE
    经验分享:5月份投稿,今天接收的,两次大修直接accept,编辑很好

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2174024, encodeId=de9a21e40243c, content=审稿速度:12.0 | 投稿命中率:75.0<br>偏重的研究方向:PE<br>经验分享:5月份投稿,今天接收的,两次大修直接accept,编辑很好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ca58126637, createdName=ms7000000341210053, createdTime=Sun Dec 10 13:19:19 CST 2023, time=2023-12-10, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2164658, encodeId=97ff21646585b, content=Awaiting Reviewer Selection需要多久?已投稿2周还是这个状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/4UjrU2XV6eQeXoLxSau95Fn1q1qGfJSw9gYZsHKr3lVESVxDfUMiahTuIQfzSe87XNvZfuI7GJqFENbgqYIHKmA/132, createdBy=16c22203057, createdName=乐观的526, createdTime=Tue Oct 24 17:39:19 CST 2023, time=2023-10-24, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=1106972, encodeId=34b411069e2d0, content=IF是什么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Wed Dec 29 14:52:53 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1106971, encodeId=35c011069e127, content=长篇幅讨论是否展示作者对课题的思考?审稿人对MS印象好?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Wed Dec 29 14:52:53 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1081300, encodeId=168010813007f, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:肺动脉高压<br>经验分享:2020年成功发表了一篇,近期有一篇收到收录通知,但是通知出版商更改了,请知情的亲们告知是否这样, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=182, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d5662461428, createdName=1241ab49m01(暂无昵称), createdTime=Fri Dec 17 21:33:20 CST 2021, time=2021-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562464, encodeId=38e6562464e1, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:个人感觉很好的一个杂志,投的肺血管病相关的meta,大修一次小修一次然后接收,要收OA费用, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=355, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200616/8841a9ca101a4fd9bdba0dd8498a9e0d/3f033a568887417cba0f0a9a4d0ac943.jpg, createdBy=d4671707910, createdName=ms5000001929854262, createdTime=Sun Oct 28 00:00:00 CST 2018, time=2018-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=846521, encodeId=dadf84652152, content=心血管的好期刊还是挺多,这个只能算是很普通的期刊。想投高分的就考虑换一个 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=300, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7a645414058, createdName=ms2534931155419844, createdTime=Wed Aug 22 16:39:27 CST 2018, time=2018-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544670, encodeId=94d75446e092, content=我只是想添加一个IF..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=419, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=04d11730917, createdName=jdsf1291, createdTime=Fri Jul 21 11:04:00 CST 2017, time=2017-07-21, status=1, ipAttribution=)]
    2023-10-24 乐观的526 来自河北省

    Awaiting Reviewer Selection需要多久?已投稿2周还是这个状态

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=2174024, encodeId=de9a21e40243c, content=审稿速度:12.0 | 投稿命中率:75.0<br>偏重的研究方向:PE<br>经验分享:5月份投稿,今天接收的,两次大修直接accept,编辑很好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ca58126637, createdName=ms7000000341210053, createdTime=Sun Dec 10 13:19:19 CST 2023, time=2023-12-10, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2164658, encodeId=97ff21646585b, content=Awaiting Reviewer Selection需要多久?已投稿2周还是这个状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/4UjrU2XV6eQeXoLxSau95Fn1q1qGfJSw9gYZsHKr3lVESVxDfUMiahTuIQfzSe87XNvZfuI7GJqFENbgqYIHKmA/132, createdBy=16c22203057, createdName=乐观的526, createdTime=Tue Oct 24 17:39:19 CST 2023, time=2023-10-24, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=1106972, encodeId=34b411069e2d0, content=IF是什么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Wed Dec 29 14:52:53 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1106971, encodeId=35c011069e127, content=长篇幅讨论是否展示作者对课题的思考?审稿人对MS印象好?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Wed Dec 29 14:52:53 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1081300, encodeId=168010813007f, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:肺动脉高压<br>经验分享:2020年成功发表了一篇,近期有一篇收到收录通知,但是通知出版商更改了,请知情的亲们告知是否这样, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=182, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d5662461428, createdName=1241ab49m01(暂无昵称), createdTime=Fri Dec 17 21:33:20 CST 2021, time=2021-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562464, encodeId=38e6562464e1, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:个人感觉很好的一个杂志,投的肺血管病相关的meta,大修一次小修一次然后接收,要收OA费用, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=355, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200616/8841a9ca101a4fd9bdba0dd8498a9e0d/3f033a568887417cba0f0a9a4d0ac943.jpg, createdBy=d4671707910, createdName=ms5000001929854262, createdTime=Sun Oct 28 00:00:00 CST 2018, time=2018-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=846521, encodeId=dadf84652152, content=心血管的好期刊还是挺多,这个只能算是很普通的期刊。想投高分的就考虑换一个 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=300, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7a645414058, createdName=ms2534931155419844, createdTime=Wed Aug 22 16:39:27 CST 2018, time=2018-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544670, encodeId=94d75446e092, content=我只是想添加一个IF..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=419, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=04d11730917, createdName=jdsf1291, createdTime=Fri Jul 21 11:04:00 CST 2017, time=2017-07-21, status=1, ipAttribution=)]
    2021-12-29 小动量

    IF是什么?

    3

    展开3条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=2174024, encodeId=de9a21e40243c, content=审稿速度:12.0 | 投稿命中率:75.0<br>偏重的研究方向:PE<br>经验分享:5月份投稿,今天接收的,两次大修直接accept,编辑很好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ca58126637, createdName=ms7000000341210053, createdTime=Sun Dec 10 13:19:19 CST 2023, time=2023-12-10, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2164658, encodeId=97ff21646585b, content=Awaiting Reviewer Selection需要多久?已投稿2周还是这个状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/4UjrU2XV6eQeXoLxSau95Fn1q1qGfJSw9gYZsHKr3lVESVxDfUMiahTuIQfzSe87XNvZfuI7GJqFENbgqYIHKmA/132, createdBy=16c22203057, createdName=乐观的526, createdTime=Tue Oct 24 17:39:19 CST 2023, time=2023-10-24, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=1106972, encodeId=34b411069e2d0, content=IF是什么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Wed Dec 29 14:52:53 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1106971, encodeId=35c011069e127, content=长篇幅讨论是否展示作者对课题的思考?审稿人对MS印象好?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Wed Dec 29 14:52:53 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1081300, encodeId=168010813007f, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:肺动脉高压<br>经验分享:2020年成功发表了一篇,近期有一篇收到收录通知,但是通知出版商更改了,请知情的亲们告知是否这样, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=182, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d5662461428, createdName=1241ab49m01(暂无昵称), createdTime=Fri Dec 17 21:33:20 CST 2021, time=2021-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562464, encodeId=38e6562464e1, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:个人感觉很好的一个杂志,投的肺血管病相关的meta,大修一次小修一次然后接收,要收OA费用, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=355, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200616/8841a9ca101a4fd9bdba0dd8498a9e0d/3f033a568887417cba0f0a9a4d0ac943.jpg, createdBy=d4671707910, createdName=ms5000001929854262, createdTime=Sun Oct 28 00:00:00 CST 2018, time=2018-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=846521, encodeId=dadf84652152, content=心血管的好期刊还是挺多,这个只能算是很普通的期刊。想投高分的就考虑换一个 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=300, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7a645414058, createdName=ms2534931155419844, createdTime=Wed Aug 22 16:39:27 CST 2018, time=2018-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544670, encodeId=94d75446e092, content=我只是想添加一个IF..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=419, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=04d11730917, createdName=jdsf1291, createdTime=Fri Jul 21 11:04:00 CST 2017, time=2017-07-21, status=1, ipAttribution=)]
    2021-12-29 ms6000000264964247

    长篇幅讨论是否展示作者对课题的思考?审稿人对MS印象好?

    1

    展开1条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=2174024, encodeId=de9a21e40243c, content=审稿速度:12.0 | 投稿命中率:75.0<br>偏重的研究方向:PE<br>经验分享:5月份投稿,今天接收的,两次大修直接accept,编辑很好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ca58126637, createdName=ms7000000341210053, createdTime=Sun Dec 10 13:19:19 CST 2023, time=2023-12-10, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2164658, encodeId=97ff21646585b, content=Awaiting Reviewer Selection需要多久?已投稿2周还是这个状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/4UjrU2XV6eQeXoLxSau95Fn1q1qGfJSw9gYZsHKr3lVESVxDfUMiahTuIQfzSe87XNvZfuI7GJqFENbgqYIHKmA/132, createdBy=16c22203057, createdName=乐观的526, createdTime=Tue Oct 24 17:39:19 CST 2023, time=2023-10-24, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=1106972, encodeId=34b411069e2d0, content=IF是什么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Wed Dec 29 14:52:53 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1106971, encodeId=35c011069e127, content=长篇幅讨论是否展示作者对课题的思考?审稿人对MS印象好?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Wed Dec 29 14:52:53 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1081300, encodeId=168010813007f, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:肺动脉高压<br>经验分享:2020年成功发表了一篇,近期有一篇收到收录通知,但是通知出版商更改了,请知情的亲们告知是否这样, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=182, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d5662461428, createdName=1241ab49m01(暂无昵称), createdTime=Fri Dec 17 21:33:20 CST 2021, time=2021-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562464, encodeId=38e6562464e1, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:个人感觉很好的一个杂志,投的肺血管病相关的meta,大修一次小修一次然后接收,要收OA费用, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=355, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200616/8841a9ca101a4fd9bdba0dd8498a9e0d/3f033a568887417cba0f0a9a4d0ac943.jpg, createdBy=d4671707910, createdName=ms5000001929854262, createdTime=Sun Oct 28 00:00:00 CST 2018, time=2018-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=846521, encodeId=dadf84652152, content=心血管的好期刊还是挺多,这个只能算是很普通的期刊。想投高分的就考虑换一个 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=300, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7a645414058, createdName=ms2534931155419844, createdTime=Wed Aug 22 16:39:27 CST 2018, time=2018-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544670, encodeId=94d75446e092, content=我只是想添加一个IF..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=419, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=04d11730917, createdName=jdsf1291, createdTime=Fri Jul 21 11:04:00 CST 2017, time=2017-07-21, status=1, ipAttribution=)]
    2021-12-17 1241ab49m01(暂无昵称)

    审稿速度:2.0 | 投稿命中率:50.0
    偏重的研究方向:肺动脉高压
    经验分享:2020年成功发表了一篇,近期有一篇收到收录通知,但是通知出版商更改了,请知情的亲们告知是否这样

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=2174024, encodeId=de9a21e40243c, content=审稿速度:12.0 | 投稿命中率:75.0<br>偏重的研究方向:PE<br>经验分享:5月份投稿,今天接收的,两次大修直接accept,编辑很好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ca58126637, createdName=ms7000000341210053, createdTime=Sun Dec 10 13:19:19 CST 2023, time=2023-12-10, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2164658, encodeId=97ff21646585b, content=Awaiting Reviewer Selection需要多久?已投稿2周还是这个状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/4UjrU2XV6eQeXoLxSau95Fn1q1qGfJSw9gYZsHKr3lVESVxDfUMiahTuIQfzSe87XNvZfuI7GJqFENbgqYIHKmA/132, createdBy=16c22203057, createdName=乐观的526, createdTime=Tue Oct 24 17:39:19 CST 2023, time=2023-10-24, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=1106972, encodeId=34b411069e2d0, content=IF是什么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Wed Dec 29 14:52:53 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1106971, encodeId=35c011069e127, content=长篇幅讨论是否展示作者对课题的思考?审稿人对MS印象好?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Wed Dec 29 14:52:53 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1081300, encodeId=168010813007f, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:肺动脉高压<br>经验分享:2020年成功发表了一篇,近期有一篇收到收录通知,但是通知出版商更改了,请知情的亲们告知是否这样, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=182, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d5662461428, createdName=1241ab49m01(暂无昵称), createdTime=Fri Dec 17 21:33:20 CST 2021, time=2021-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562464, encodeId=38e6562464e1, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:个人感觉很好的一个杂志,投的肺血管病相关的meta,大修一次小修一次然后接收,要收OA费用, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=355, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200616/8841a9ca101a4fd9bdba0dd8498a9e0d/3f033a568887417cba0f0a9a4d0ac943.jpg, createdBy=d4671707910, createdName=ms5000001929854262, createdTime=Sun Oct 28 00:00:00 CST 2018, time=2018-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=846521, encodeId=dadf84652152, content=心血管的好期刊还是挺多,这个只能算是很普通的期刊。想投高分的就考虑换一个 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=300, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7a645414058, createdName=ms2534931155419844, createdTime=Wed Aug 22 16:39:27 CST 2018, time=2018-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544670, encodeId=94d75446e092, content=我只是想添加一个IF..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=419, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=04d11730917, createdName=jdsf1291, createdTime=Fri Jul 21 11:04:00 CST 2017, time=2017-07-21, status=1, ipAttribution=)]
    2018-10-28 ms5000001929854262

    审稿速度:2.0 | 投稿命中率:50.0
    经验分享:个人感觉很好的一个杂志,投的肺血管病相关的meta,大修一次小修一次然后接收,要收OA费用

    1

    展开1条回复
  7. [GetPortalCommentsPageByObjectIdResponse(id=2174024, encodeId=de9a21e40243c, content=审稿速度:12.0 | 投稿命中率:75.0<br>偏重的研究方向:PE<br>经验分享:5月份投稿,今天接收的,两次大修直接accept,编辑很好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ca58126637, createdName=ms7000000341210053, createdTime=Sun Dec 10 13:19:19 CST 2023, time=2023-12-10, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2164658, encodeId=97ff21646585b, content=Awaiting Reviewer Selection需要多久?已投稿2周还是这个状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/4UjrU2XV6eQeXoLxSau95Fn1q1qGfJSw9gYZsHKr3lVESVxDfUMiahTuIQfzSe87XNvZfuI7GJqFENbgqYIHKmA/132, createdBy=16c22203057, createdName=乐观的526, createdTime=Tue Oct 24 17:39:19 CST 2023, time=2023-10-24, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=1106972, encodeId=34b411069e2d0, content=IF是什么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Wed Dec 29 14:52:53 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1106971, encodeId=35c011069e127, content=长篇幅讨论是否展示作者对课题的思考?审稿人对MS印象好?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Wed Dec 29 14:52:53 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1081300, encodeId=168010813007f, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:肺动脉高压<br>经验分享:2020年成功发表了一篇,近期有一篇收到收录通知,但是通知出版商更改了,请知情的亲们告知是否这样, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=182, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d5662461428, createdName=1241ab49m01(暂无昵称), createdTime=Fri Dec 17 21:33:20 CST 2021, time=2021-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562464, encodeId=38e6562464e1, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:个人感觉很好的一个杂志,投的肺血管病相关的meta,大修一次小修一次然后接收,要收OA费用, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=355, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200616/8841a9ca101a4fd9bdba0dd8498a9e0d/3f033a568887417cba0f0a9a4d0ac943.jpg, createdBy=d4671707910, createdName=ms5000001929854262, createdTime=Sun Oct 28 00:00:00 CST 2018, time=2018-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=846521, encodeId=dadf84652152, content=心血管的好期刊还是挺多,这个只能算是很普通的期刊。想投高分的就考虑换一个 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=300, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7a645414058, createdName=ms2534931155419844, createdTime=Wed Aug 22 16:39:27 CST 2018, time=2018-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544670, encodeId=94d75446e092, content=我只是想添加一个IF..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=419, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=04d11730917, createdName=jdsf1291, createdTime=Fri Jul 21 11:04:00 CST 2017, time=2017-07-21, status=1, ipAttribution=)]
    2018-08-22 ms2534931155419844

    心血管的好期刊还是挺多,这个只能算是很普通的期刊。想投高分的就考虑换一个

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=2174024, encodeId=de9a21e40243c, content=审稿速度:12.0 | 投稿命中率:75.0<br>偏重的研究方向:PE<br>经验分享:5月份投稿,今天接收的,两次大修直接accept,编辑很好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ca58126637, createdName=ms7000000341210053, createdTime=Sun Dec 10 13:19:19 CST 2023, time=2023-12-10, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2164658, encodeId=97ff21646585b, content=Awaiting Reviewer Selection需要多久?已投稿2周还是这个状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/4UjrU2XV6eQeXoLxSau95Fn1q1qGfJSw9gYZsHKr3lVESVxDfUMiahTuIQfzSe87XNvZfuI7GJqFENbgqYIHKmA/132, createdBy=16c22203057, createdName=乐观的526, createdTime=Tue Oct 24 17:39:19 CST 2023, time=2023-10-24, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=1106972, encodeId=34b411069e2d0, content=IF是什么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Wed Dec 29 14:52:53 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1106971, encodeId=35c011069e127, content=长篇幅讨论是否展示作者对课题的思考?审稿人对MS印象好?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Wed Dec 29 14:52:53 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1081300, encodeId=168010813007f, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:肺动脉高压<br>经验分享:2020年成功发表了一篇,近期有一篇收到收录通知,但是通知出版商更改了,请知情的亲们告知是否这样, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=182, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d5662461428, createdName=1241ab49m01(暂无昵称), createdTime=Fri Dec 17 21:33:20 CST 2021, time=2021-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562464, encodeId=38e6562464e1, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:个人感觉很好的一个杂志,投的肺血管病相关的meta,大修一次小修一次然后接收,要收OA费用, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=355, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200616/8841a9ca101a4fd9bdba0dd8498a9e0d/3f033a568887417cba0f0a9a4d0ac943.jpg, createdBy=d4671707910, createdName=ms5000001929854262, createdTime=Sun Oct 28 00:00:00 CST 2018, time=2018-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=846521, encodeId=dadf84652152, content=心血管的好期刊还是挺多,这个只能算是很普通的期刊。想投高分的就考虑换一个 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=300, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7a645414058, createdName=ms2534931155419844, createdTime=Wed Aug 22 16:39:27 CST 2018, time=2018-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544670, encodeId=94d75446e092, content=我只是想添加一个IF..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=419, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=04d11730917, createdName=jdsf1291, createdTime=Fri Jul 21 11:04:00 CST 2017, time=2017-07-21, status=1, ipAttribution=)]
    2017-07-21 jdsf1291

    我只是想添加一个IF...

    0

共12条页码: 1/2页10条/页
分享您的投稿经验,提升MI经验值,获取更多积分